Mayne Pharma Group Limited Stock: price and insider trades · Australia
Mayne Pharma Group Limited: what insiders have been doing
This page follows insider dealings at Mayne Pharma Group Limited as filed with ASX, a company from the Health Care sector based in Salisbury, Australia. The group dates from 1845. From 25 October 2025 to 25 October 2026, the disclosure feed for Mayne Pharma Group Limited logged 5 filings by 4 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Across the 1,596 companies tracked on its exchange, the median is 4 filings; at 5 filings, this issuer sits above that mark.
No insider has bought Mayne Pharma Group Limited shares on the open market in the past twelve months.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Key facts
Headquarters: Salisbury, Australia · Founded: 1845
Source: Wikidata (CC0).
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
- ShareASXISIN AU000000MYX0ASX:2924-03121337-3A698847
- ShareASXASX:2924-03106183-3A696353
- ShareASXISIN AU000000MYX0ASX:2924-03104206-3A696027
- ShareASXASX:2924-03101567-3A695560
- ShareASXASX:2924-03097785-3A694841
5 of 5 declarations
About Mayne Pharma Group Limited
Mayne Pharma Group Limited is an Australian pharmaceutical company focused on the development and commercialization of generic and branded pharmaceutical products. It is listed on the Australian Securities Exchange under the ticker MYX.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
